Chemotherapy in Wilms' tumor--indications and early side effects.
D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003609:Dactinomycin / Q000009:adverse effects; D004317:Doxorubicin / Q000009:adverse effects; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D014750:Vincristine / Q000009:adverse effects; D009396:Wilms Tumor / Q000188:drug therapy*
D000970:Antineoplastic Agents; D003609:Dactinomycin; D014750:Vincristine; D004317:Doxorubicin